The Life Sciences industry is undergoing transformation. Changing regulatory requirements, fewer new patents and changing corporate strategy have life sciences executives grappling with complex issues:
A Changing Product Mix requires a distribution network that can accommodate specialty pharma, generic drugs and cold storage needs.
Speed to Launch is a key to the lifetime profitability of a drug, and distribution networks should enable this.
The Generic Wave is changing the dynamics of industry margins, and streamlining distribution costs is imperative to remain competitive.
Supply Chain Integrity is critical as companies face increasing scrutiny over supply disruptions and counterfeit security.
Pedigree Requirements are necessitating investments in your technology, distribution and transportation networks.
“Fortna helps Life Sciences companies balance optimizing distribution operations for speed and cost with complying with increasingly complex pedigree requirements.”